We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.65B
AUM Growth
+$261M
Cap. Flow
+$78.3M
Cap. Flow %
4.75%
Top 10 Hldgs %
30.91%
Holding
4,786
New
852
Increased
1,597
Reduced
1,330
Closed
889

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$312M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$45M
3
IWV icon
iShares Russell 3000 ETF
IWV
+$16.5M
4
IVW icon
iShares S&P 500 Growth ETF
IVW
+$8.03M
5
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$6.59M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$94.8M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$58.6M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$41.6M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$30.2M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$16M

Sector Composition

Rank Sector Weight
1 Technology 7.61%
2 Financials 6.35%
3 Industrials 4.92%
4 Healthcare 4.88%
5 Consumer Discretionary 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UAN icon
2301
CVR Partners
UAN
$1.24B
$19K ﹤0.01%
+479
New +$18.2K
USD icon
2302
ProShares Ultra Semiconductors
USD
$2.85B
$19K ﹤0.01%
7,248
-228,432
-97% -$521K
UTHR icon
2303
United Therapeutics
UTHR
$22.7B
$19K ﹤0.01%
+163
New +$19K
WTI icon
2304
W&T Offshore
WTI
$578M
$19K ﹤0.01%
2,700
-18,826
-87% -$102K
XENE icon
2305
Xenon Pharmaceuticals
XENE
$6.14B
$19K ﹤0.01%
1,870
+1,606
+608% +$13.6K
XXII
2306
22nd Century Group
XXII
$1.55M
– –
0
– –
TCRR
2307
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$19K ﹤0.01%
+1,081
New +$19.2K
PBFX
2308
DELISTED
PBF LOGISTICS LP
PBFX
$19K ﹤0.01%
891
+791
+791% +$17.1K
JMEI
2309
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$19K ﹤0.01%
+798
New +$18.8K
TOO
2310
DELISTED
Teekay Offshore Partners L.P.
TOO
$19K ﹤0.01%
+15,883
New +$20.1K
MLNT
2311
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$19K ﹤0.01%
5,303
+4,460
+529% +$24.2K
EMCI
2312
DELISTED
EMC INS Group Inc
EMCI
$19K ﹤0.01%
609
-607
-50% -$19.4K
HZNP
2313
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$19K ﹤0.01%
+700
New +$16.6K
DOC
2314
DELISTED
PHYSICIANS REALTY TRUST
DOC
$19K ﹤0.01%
1,000
+900
+900% +$16K
APLE icon
2315
Apple Hospitality REIT
APLE
$3.69B
$18K ﹤0.01%
1,119
+1,076
+2,502% +$17.2K
AVTX icon
2316
Avalo Therapeutics
AVTX
$1.05B
$18K ﹤0.01%
1
– –
CCB icon
2317
Coastal Financial
CCB
$736M
$18K ﹤0.01%
+1,054
New +$16.6K
CRD.A icon
2318
Crawford & Co Class A
CRD.A
$642M
$18K ﹤0.01%
1,904
-2,513
-57% -$24.2K
DWLD icon
2319
Davis Select Worldwide ETF
DWLD
$616M
$18K ﹤0.01%
+794
New +$17.6K
EXK
2320
Endeavour Silver
EXK
$3.02B
$18K ﹤0.01%
7,075
-4,851
-41% -$11.5K
FWONA icon
2321
Liberty Media Series A
FWONA
$23.3B
$18K ﹤0.01%
+542
New +$16.4K
CBIO
2322
Crescent Biopharma
CBIO
$637M
$18K ﹤0.01%
+14
New +$16K
GNE icon
2323
Genie Energy
GNE
$377M
$18K ﹤0.01%
2,107
-944
-31% -$7.89K
HNNA icon
2324
Hennessy Advisors
HNNA
$77.9M
$18K ﹤0.01%
1,932
-1,152
-37% -$12K
IPAR icon
2325
Interparfums
IPAR
$3.78B
$18K ﹤0.01%
+243
New +$17K
91 92
93
94 95

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2019 Portfolio in Review

As of Q1 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.65B, up 19% from $1.39B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Tower Research Capital (TRC) deployed $78.3M of net new capital in Q1 2019, opening 852 new positions and adding to 1,597 existing holdings. Its largest new stake was iShares MSCI USA Momentum Factor ETF: 56,999 shares worth $6.39M.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $94.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2019 buy was iShares MSCI USA Momentum Factor ETF: 56,999 shares worth $6.39M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2019, an estimated $312M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $94.8M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q1 2019, selling an estimated $6.12M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 31% of its $1.65B portfolio in Q1 2019.
  • Tower Research Capital (TRC) opened 852 new positions and closed 889 in Q1 2019.
  • Tower Research Capital (TRC)'s portfolio value rose 19% quarter-over-quarter to $1.65B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2019, filed 14 May 2019.